Interestingly, TfR1 expression was upregulated in a dose-dependent manner during sulfasalazine treatment in breast cancer cells, indicating that activation of TfR1 may participate in sulfasalazine-induced ferroptosis [50]. The gene discussed is TFRC; the disease is breast carcinoma.